Method for improving fibrosis of glomerular mesangial cells of diabetic nephropathy by regulating and controlling autophagy through TSC2-mTOR path by using Hunk protein
By constructing a mouse model and cell culture system for diabetic nephropathy, Hunk protein overexpression and TSC2-mTOR pathway regulate autophagy, the role of fibrosis in diabetic nephropathy is studied, providing new treatment ideas and improving renal damage of diabetic nephropathy .
Patent Information
- Application Number
- CN202410610381.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-05-16
- Publication Date
- 2024-11-26
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
In diabetic nephropathy, fibrosis of mesangial cells is an important mechanism that causes kidney damage, but the specific mechanism of action of Hunk protein in this process has not been clarified in the prior art.
By constructing a mouse model and cell culture system for diabetic nephropathy, Hunk protein overexpression and TSC2-mTOR pathway regulate autophagy, and its effect on improving the fibrosis of mesangial glomerulus in diabetic nephropathy was explored.
The mechanism of action of Hunk protein in diabetic nephropathy was systematically studied, providing new research directions and potential therapeutic targets for the treatment of diabetic nephropathy, reducing the production of fibrotic proteins by regulating the autophagy pathway and improving renal damage.
Smart Images

Figure CN119015419A_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the field of biotechnology, and specifically is a method for improving glomerular mesangial cell fibrosis in diabetic nephropathy by regulating autophagy through the TSC2-mTOR pathway using Hunk protein, exploring the effects of changes in glomerular mesangial cell autophagy on renal fibrosis in high glucose / diabetes, and further clarifying the mechanism of action of Hunk protein in improving renal fibrosis in diabetic nephropathy by regulating autophagy through the TSC2-mTOR pathway. Background Art
[0002] With the development of diabetes, microvascular complications have a huge impact on the quality of life of diabetic patients, among which diabetic nephropathy (DN) is the most common. High-sugar environment leads to glomerular mesangial cell (MC) fibrosis, which is one of the pathogenesis of DN. Renal cell-based autophagy is an important part of kidney structure, kidney homeostasis and function maintenance. Studying changes in MC autophagy helps to understand the pathogenesis of DN. Hormonally up-regulated Neu-associated Kinase (Hunk) has serine / threonine protein kinase activity and is widely expressed in various tissues of the human body. Studies have shown that there is a close connection between Hunk protein and autophagy, but its specific mechanism in the progression of diabetic nephropathy has not yet been clarified.
[0003] To this end, those skilled in the art have proposed a method for using Hunk protein to regulate autophagy through the TSC2-mTOR pathway to improve glomerular mesangial cell fibrosis in diabetic nephropathy to solve the problems raised by the background technology. Summary of the invention
[0004] In order to solve the above technical problems, the present invention provides a method for improving glomerular mesangial cell fibrosis in diabetic nephropathy by regulating autophagy through the TSC2-mTOR pathway using Hunk protein, so as to solve the problems in the prior art.
[0005] A method for improving glomerular mesangial cell fibrosis in diabetic nephropathy by regulating autophagy through the TSC2-mTOR pathway using Hunk protein, comprising the following steps:
[0006] S1. Construction of diabetic nephropathy mouse model: BKS-db / db mice were used to establish a diabetic nephropathy (DN) mouse model;
[0007] S2. Detection of indicators and pathological evaluation of DN mice. First, the metabolic indicators and renal function of DN mice were comprehensively tested. Then, the renal sections were pathologically evaluated using HE, Masson, and PAS staining techniques. Then, Western Blot and immunohistochemical staining techniques were used to detect the distribution and expression of fibrosis proteins (FN, Col IV, α-SMA), autophagy marker proteins (LC3, Beclin-1, p62), and Hunk proteins in the renal cortex. By constructing a diabetic nephropathy mouse model and conducting comprehensive metabolic indicators, renal function tests, and pathological evaluations, the development process of human diabetic nephropathy can be accurately simulated, providing a reliable experimental basis for subsequent research. At the same time, by detecting the distribution and expression of fibrosis proteins in the renal cortex, we can have a deeper understanding of the occurrence and development mechanism of fibrosis in diabetic nephropathy.
[0008] S3. Setting of cell culture conditions: Rat mesangial cells (RMC) were cultured and two culture medium environments, low sugar and high sugar, were set respectively. By setting two culture environments, the effects of different sugar concentrations on mesangial cells can be compared and observed;
[0009] S4. Overexpression of Hunk protein: Overexpression of Hunk protein was achieved by transiently transfecting RMC with pcDNA 3.1-Hunk plasmid. Overexpression of Hunk protein was achieved by plasmid transfection and its expression level was verified, which is helpful to understand the role of Hunk protein in glomerular mesangial cells.
[0010] S5. Verify Hunk protein expression: Use Western Blot technology to detect the expression level of Hunk protein in RMC to confirm the transfection effect;
[0011] S6. Detection of cell autophagy function: Cultivate RMC in a high-glucose environment and use the autophagy activator rapamycin for intervention, and then use Western Blot technology to detect the expression of autophagy marker proteins (LC3, Beclin-1, p62) to explore the effect of enhancing Hunk expression on high-glucose-induced RMC autophagy. By detecting the expression of autophagy marker proteins, the effect of Hunk protein overexpression on autophagy function can be observed, and then its improvement effect on diabetic nephropathy can be explored;
[0012] S7. Evaluation of the degree of cell fibrosis: Western Blot technology was used to detect the expression of fibrotic proteins (FN, ColIV, α-SMA) in RMC, and the effect of Hunk overexpression on high glucose-induced RMC fibrosis was evaluated. By detecting the expression of fibrotic proteins, the effect of Hunk overexpression on high glucose-induced glomerular mesangial cell fibrosis can be evaluated, providing a basis for finding new treatment strategies.
[0013] S8. Cell signaling pathway analysis: To explore the effect of enhancing Hunk expression on the expression of TSC2-mTOR pathway proteins (p-TSC2, TSC2, p-mTOR, mTOR) in high glucose-induced RMC, in order to parse out the molecular mechanism of Hunk protein in diabetic nephropathy. To explore the effect of Hunk protein on the expression of TSC2-mTOR pathway proteins will help to parse out the molecular mechanism of Hunk protein in diabetic nephropathy and provide new ideas for future drug development and treatment.
[0014] Preferably, in step S1, the method steps for comprehensively detecting metabolic indicators and renal function of DN mice are as follows:
[0015] 1) Metabolic index detection: First, select DN mice, then weigh and record the DN mice, and then measure them at the same time every day using the same scale. Avoid eating or drinking before measurement to ensure accurate results and complete the detection of metabolic indicators of DN mice;
[0016] 2) Renal function test: First, select DN mice, and then use appropriate needles, syringes, centrifuge tubes and other equipment to collect blood samples from the mice. After blood collection, immediately put the blood into a centrifuge tube and let it stand at room temperature for 2 hours. Centrifuge the blood sample at 2000rpm / min for 10-15 minutes, separate the serum, and transfer it to a clean centrifuge tube. Then, perform serum urea nitrogen and creatinine tests according to the kit instructions, analyze the test results, and then obtain the renal function status of DN mice.
[0017] Preferably, the HE staining operation steps are as follows: first, kidney tissue of DN mice is selected, and then the kidney tissue block is placed in a 4% formaldehyde solution for fixation for 24 hours, and the fixed tissue block is placed in 50%, 70%, 80%, and 90% alcohol solutions for dehydration in turn, each time for 1-2 hours, and the dehydrated tissue block is placed in a xylene solution for transparency twice, each time for 15-20 minutes, and then placed in a paraffin solution for wax immersion twice, each time for 1-2 hours, and the wax-immersed tissue block is paraffin-sectioned with a thickness of 5-8 μm, and the slices are placed on a drying rack for drying, and the slices are placed in HE staining solution for staining for 10-15 minutes, and then the residual staining solution is rinsed off with water, and the stained slices are sealed with neutral gum, and observed and recorded with an optical microscope;
[0018] The Masson staining operation steps are as follows: first, cut or pick out slices of appropriate size from the tissue specimen, the slice thickness is 3-5 μm, then place the slices on a slide, then place the slide in a dewaxing solvent until all the paraffin is removed, then place the slide in 96% ethanol for 3-5 minutes, then rinse the slide with distilled water for 30-40 seconds, then place the slide in an eosin solution for 5-10 minutes to stain mitochondria and calcium salts, wash the slide with distilled water for 30-40 seconds, and place the slide in a malignant blue solution for 1-2 minutes, To stain muscle fibers and cell nuclei, rinse the slides thoroughly with distilled water for 30-40 seconds, place the slides in hematoxylin stain for 5-10 minutes, to stain collagen fibers and the matrix surrounding collagen, rinse the slides thoroughly with distilled water for 30 seconds, immerse the slides in 2% alcohol, let stand for 3-5 minutes, then immerse the slides in 95% alcohol, wash again for 3-5 minutes, then immerse the slides in absolute ethanol and styrene in turn to gradually dehydrate them, then place the slides in a transparent agent, dry them in a 60°C constant temperature box, and finally seal the slides with sealing glue;
[0019] The operation steps of PAS staining are as follows: first, the slices are routinely dewaxed, then washed with distilled water for 1-2 minutes, then oxidized with periodic acid solution for 10-15 minutes, then washed with distilled water again for 1-2 minutes, then stained with Schiff reagent for 10-15 minutes, then rinsed with running water for 1-2 minutes, then stained with hematoxylin solution for 2-4 minutes, then rinsed with running water for anti-blueing for 3-5 minutes, preferably dehydrated and transparent, sealed with neutral gum, observed and recorded under an optical microscope.
[0020] Preferably, the Western Blot is used to detect the expression level of the protein in the sample and provide qualitative and quantitative information, the immunohistochemical staining is used to observe the localization and distribution of the protein in the tissue, and can provide information at the cellular level. The operating steps of using Western Blot and immunohistochemical staining techniques to detect the distribution and expression of fibrosis proteins (FN, Col IV, α-SMA), autophagy marker proteins (LC3, Beclin-1, p62) and Hunk proteins in the renal cortex are as follows: first, a renal cortex sample is obtained and properly processed, including tissue fragmentation and protein extraction; Western Blot analysis: protein extraction and concentration, SDS-PAGE electrophoresis to separate the protein, transfer to a membrane, use specific antibodies for immune reaction, use chemiluminescence or fluorescence to detect signals, analyze data and compare protein expression levels between different samples; immunohistochemical staining: prepare tissue sections, perform protein antibody staining, perform color development reaction, and observe the distribution of the protein under a microscope.
[0021] Preferably, pcDNA 3.1 is a commonly used eukaryotic expression vector for expressing foreign proteins in mammalian cells. Inserting the Hunk gene into the pcDNA 3.1 vector can construct a pcDNA 3.1-Hunk plasmid.
[0022] Preferably, in step S5, the Western Blot technique detection operation steps are as follows:
[0023] S5.1. Protein extraction: Collect RMC cells and perform appropriate treatment, such as exposure to PBS, lyse cells with cell lysis buffer and lyse proteins;
[0024] S5.2. Determine protein content: BCA protein quantification kit or other appropriate methods can be used;
[0025] S5.3, SDS-PAGE electrophoresis: separate the protein samples into SDS-PAGE gel;
[0026] S5.4, membrane transfer: transfer the proteins in the SDS-PAGE gel to the polymer membrane for Western Blot reaction;
[0027] S5.5, Blocking and antibody reaction: Block the membrane with 5% non-fat milk powder or other proteins, and add Hunk antibody reaction. You can choose a primary antibody labeled with an enzyme (such as HRP) and a secondary antibody labeled with a fluorescent substance to react and detect the protein level;
[0028] S5.6. Color development: Use horseradish peroxidase substrate or other suitable color developing agent to develop the target protein;
[0029] S5.7 Image analysis: Quantify and analyze proteins using image analysis software.
[0030] Compared with the prior art, the present invention has the following beneficial effects:
[0031] The present invention can accurately simulate the development process of human diabetic nephropathy by constructing a diabetic nephropathy mouse model and conducting comprehensive metabolic indicators, renal function tests and pathological evaluations, providing a reliable experimental basis for subsequent research. Through various experimental designs and detection methods, the mechanism of action of Hunk protein in diabetic nephropathy is systematically studied, providing a new research direction and potential therapeutic target for the treatment of diabetic nephropathy. BRIEF DESCRIPTION OF THE DRAWINGS
[0032] Figure 1The figure is a schematic diagram of the body weight, blood sugar and renal function of the BKS-db / db mice of the present invention; wherein, A: body weight; B: fasting blood sugar; C: 24 urine protein quantification; D: urine microalbumin / creatinine ratio (ACR); NC: non-diabetic control group mice, i.e., db / m mice; DN: diabetic nephropathy group mice, i.e., db / db mice; 16w-NC: 16-week-old non-diabetic control group mice; 16w-DN: 16-week-old diabetic nephropathy group mice; compared with the NC group, *P<0.05, **P<0.01; n=6 per group;
[0033] Figure 2 The figure is a schematic diagram of the pathological staining analysis of the renal cortex region of 16-week-old BKS-db / db mice of the present invention; wherein, A: from top to bottom, the hematoxylin-eosin (HE) staining, periodic acid-Schiff (PAS) staining and Masson trichrome staining of the renal cortex sections of mice; B, C and D: semi-quantitative statistical analysis results; NC: non-diabetic control group, i.e., db / m mice; DN: diabetic nephropathy group, i.e., db / db mice; compared with the NC group, *P<0.05; the number of images used for analysis in each group n=24; microscope magnification: 400×;
[0034] Figure 3 The diagram is a graph showing the expression of FN, Col IV and α-SMA proteins in the glomerulus of 16-week-old BKS-db / db mice of the present invention; wherein, A: immunohistochemical staining was used to detect the expression of FN, Col IV and α-SMA in the glomerulus of each group of mice at 16 weeks of age; BD: analysis of the results of immunohistochemical positive staining intensity; E: Western Blot was used to detect the expression of FN, Col IV and α-SMA in the renal cortex of each group of mice at 16 weeks of age; F: Western Blot result analysis; NC: non-diabetic control group, i.e., db / m mice; DN: diabetic nephropathy group, i.e., db / db mice; FN: Fibronectin; Col IV: Collagen IV; α-SMA: α-Smooth Muscle Actin; Tubulin: α-tubulin; compared with the NC group, *P<0.05; the number of pictures in each group used for immunohistochemical result analysis n=24; microscope magnification: 400×; the number of independent experiments used for Western Blot result analysis n=6;
[0035] Figure 4The diagram shows the expression of Hunk protein in the glomerulus and autophagy activity of 16-week-old BKS-db mice of the present invention; wherein, A: immunohistochemical detection of Hunk protein and LC3B expression in the glomerulus of each group of mice at 16 weeks of age; B: representative Western blot diagram; CD: analysis of the results of immunohistochemical positive staining intensity; EF: statistical data analysis of Western blot results; NC: non-diabetic control group, i.e., db / m mice; DN: diabetic nephropathy group, i.e., db / db mice; compared with the NC group, *P<0.05; the number of immunohistochemical images used for analysis in each group is n=24, and the microscope magnification is 400×; the number of mice used for Western Blot result analysis in each group is n=6;
[0036] Figure 5 The figure is a diagram showing the changes of fibrotic proteins, Hunk proteins and autophagy indexes in RMC induced by high glucose of the present invention; wherein, A, C and E: Western blot detection of the expression of fibrotic proteins, Hunk proteins and autophagy indexes in each group of cells; B, D and F: Western blot result analysis; RMC: rat glomerular mesangial cells; NG: normal glucose group (5.5 mM glucose); HG: high glucose group (25 mM glucose); FN: fibronectin; Col IV: type IV collagen fibers; α-SMA: α-smooth muscle actin; compared with the NG group, *P<0.05; the number of independent experiments for Western Blot result analysis in each group is n=6;
[0037] Figure 6 The figure shows that high sugar promotes the production of RMC fibrosis protein by inhibiting autophagy activity in the present invention; wherein, A: Western blot detection of the expression of autophagy proteins LC3, p62 and Beclin-1 in each group of cells; B: Western blot detection of the expression of fibrosis proteins FN, Col IV and α-SMA in each group of cells; CD: corresponding Western blot result analysis; RMC: rat glomerular mesangial cell; NG: normal sugar group (5.5mM glucose); HG: high sugar group (25mM glucose); FN: fibronectin; Col IV: type IV collagen fiber; α-SMA: α-smooth muscle actin; compared with the NG group, *P<0.05; compared with the HG group, #P<0.05; the number of independent experiments for Western Blot result analysis in each group is n=6;
[0038] Figure 7The figure shows the effect of overexpression of Hunk protein on fibrotic proteins, Hunk and autophagy indexes in RMC induced by high glucose; A, C and G: Western blot detection of fibrotic proteins, Hunk and autophagy protein expressions in each group of cells; B, DF and HJ: analysis of corresponding Western blot results; RMC: rat glomerular mesangial cells; NG: normal glucose group (5.5 mM glucose); HG: high glucose group (25 mM glucose); NC: empty plasmid group (HG+pcDNA3.1-vector); OE-Hunk: Hunk overexpression group (HG+pcDNA3.1-Hunk); FN: FN: fibronectin; Col IV: type IV collagen fibers; α-SMA: α-smooth muscle actin; compared with the NG group, *P<0.05; compared with the HG group, ns>0.05; compared with the NC group, #P<0.05; each group was used for Western The number of independent experiments for blot result analysis was n = 6;
[0039] Figure 8 Schematic diagram of the present invention showing that overexpression of Hunk improves glomerular mesangial cell fibrosis in diabetic nephropathy by regulating autophagy through the TSC2-mTOR pathway; wherein, A, E and I: representative Western blot images; BD, FH and JL: corresponding Western Blot analysis; RMC: rat glomerular mesangial cells; NG: normal glucose group (5.5 mM glucose); HG: high glucose group (25 mM glucose); NC: empty plasmid group (HG+pcDNA3.1-vector); OE-Hunk: Hunk overexpression group (HG+pcDNA3.1-Hunk); Rapa: rapamycin intervention group (HG+pcDNA3.1-Hunk+Rapamycin) FN: fibronectin; ColIV: type IV collagen fibers; α-SMA: α-smooth muscle actin; TSC2: tuberous sclerosis complex protein 2; compared with NG group, *P<0.05; compared with HG group, ns>0.05; compared with NC group, #P<0.05; compared with OE-Hunk group, ns^>0.05, &P<0.05; the number of independent experiments for Western blot analysis in each group was n=6;
[0040] Fig. 9 This is a schematic diagram of the method of reducing the Hunk protein content in glomerular mesangial cells in diabetes mellitus according to the present invention. DETAILED DESCRIPTION
[0041] The following embodiments of the present invention are described in further detail in conjunction with the accompanying drawings and examples. The following examples are used to illustrate the present invention, but are not intended to limit the scope of the present invention.
[0042] Example 1: The present invention provides a method for improving glomerular mesangial cell fibrosis in diabetic nephropathy by regulating autophagy through the TSC2-mTOR pathway using Hunk protein, including in vivo experiments and in vitro experiments:
[0043] 1. In vivo experiment: BKS-db / db DN mouse model was established. Male db / db mice were used as diabetic nephropathy group (DN), and age- and sex-matched heterozygous db / m mice were used as non-diabetic control group (NC). Each experimental group contained 6 mice. Fasting blood glucose, body weight and urine albumin / creatinine ratio (ACR) of all mice were measured. After the experiment, all mice were euthanized, blood samples were collected, and kidneys were removed after dissection. Serum was collected after blood centrifugation for the determination of blood urea nitrogen (BUN) and creatinine (Scr). Kidney sections were stained with HE, Masson, and PAS to evaluate renal pathology. Western Blot and immunohistochemical staining were used to detect fibrotic proteins fibronectin (FN), type IV collagen (Col IV), and α-smooth muscle actin (α-Smooth muscle actin) Actin, α-SMA), autophagy marker proteins (LC3, Beclin-1, p62) and Hunk protein distribution and expression in the renal cortex;
[0044] The specific description is as follows:
[0045] 1) Experimental Materials
[0046] 1.1) Experimental animals and feeding conditions
[0047] BKS-db / db mice were bred from heterozygous BKS-Leprem2Cd479 / Gpt mice. BKS-db / m heterozygous mice were used as the control group and were purchased from Jiangsu Jicui Pharmaceutical Co., Ltd. and raised in the SPF-level laboratory of the Experimental Animal Center of Fujian Medical University. The mice were fed in cages by a dedicated person. The room temperature was maintained at 23℃-25℃, the humidity was maintained at around 55%-65%, the light-dark cycle was 12h, 7AM-7PM, the feed and water were sterilized, and the drinking water, feed and bedding were replaced every 2 days after high-pressure steam sterilization. All mice had free access to water and food, and the treatment of animals throughout the experiment complied with the ethical standards for experimental animals.
[0048] 1.2) Drugs and reagents
[0049]
[0050]
[0051]
[0052]
[0053] 2) Reagent configuration
[0054] 2.1) Preparation of HE, PAS and Masson staining reagents for paraffin sections:
[0055] ①Schiff's reagent
[0056] Add 1g of basic fuchsin to 200mL of boiling distilled water, shake and stir at any time for 5min, filter into a brown bottle when cooled to 50℃, add 20mL of 1mol / L HCl and shake well; when cooled to 25℃, add 3g of Na2S2O5 (sodium metabisulfite), shake well and mix well, wrap with black paper to avoid light, and store in a dark place at 4℃ overnight; take out the next day (it should be light yellow, if it is pink, it cannot be used) add 0.5g of activated carbon and shake vigorously for 1min; after filtering, store at 4℃ away from light for later use;
[0057] ② Sulfite aqueous solution
[0058] 5 mL of 10% sodium metabisulfite aqueous solution, 15 mL of 1 mol / L HCl, and 100 mL of distilled water;
[0059] ③Regaud's hematoxylin
[0060] 1g hematoxylin, 10mL 95% alcohol, 10mL glycerol, 80mL distilled water; add hematoxylin to distilled water and heat to dissolve, add alcohol and glycerol after cooling, and it can be used after a few days;
[0061] ④Masson Ponceau Acidic Resin Solution
[0062] Mix 0.7 g of Ponceau red, 0.3 g of acid fuchsin, 99 mL of distilled water, and 1 mL of glacial acetic acid;
[0063] 2.2) Preparation of Western Blot Reagents:
[0064] ①10% ammonium persulfate (AP)
[0065]
[0066] Dissolve and mix well, then divide into small tubes and store at -20℃;
[0067] ②SDS-PAGE separation gel (20mL)
[0068]
[0069] After adding TEMED, mix well immediately and then pour the glue;
[0070] ③SDS-PAGE stacking gel (6 mL)
[0071]
[0072] After adding TEMED, mix well immediately and then pour the glue;
[0073] ④10× electrophoresis buffer
[0074]
[0075] After dissolving and mixing, store at room temperature;
[0076] ⑤1× electrophoresis buffer
[0077] Take 100mL of 10× electrophoresis buffer, add ddH2O to make up to 1L, store at room temperature, and use immediately after preparation; ⑥ 10× transfer buffer
[0078]
[0079]
[0080] After dissolving and mixing, store at room temperature;
[0081] ⑦1× transfer buffer
[0082] Take 100 mL of 10× transfer buffer, 200 mL of methanol, add ddH2O to make up to 1 L, and use it immediately.
[0083] ⑧10×TBS buffer
[0084]
[0085] After fully dissolved, adjust the pH to 7.6 with HCL, add water to 1000mL, and store the prepared 1000mL 10×TBS buffer at room temperature;
[0086] ⑨1×TBST buffer
[0087] Measure 100 mL of 10×TBS buffer and add 900 mL of ddH2O, then add 1 mL of Tween-20 and mix thoroughly to make 1×TBST buffer, which is ready for use.
[0088] ⑩5% skim milk blocking solution
[0089]
[0090] After fully mixing, store at 4℃ and use within three days. When using, it is necessary to return to room temperature. The amount of blocking solution used should be enough to cover the membrane surface. It is one-time use.
[0091] 3) Research methods
[0092] 3.1) Construction and grouping of BKS-db / db diabetic nephropathy mouse model:
[0093] The db / db type 2 diabetes mouse model was established: a. db / db model group (DN): SPF grade 7-8 week old male, obese, fasting blood glucose (FBG) level higher than 11.1 mol / L db / db mice; b. db / m normal group (NC): male db / m mice of the same age, normal body shape, FBG lower than 6.6 mol / L, all purchased from Jiangsu Jicui Pharmaceutical Kang Biotechnology Co., Ltd.; all mice were free to eat and drink during the experiment;
[0094] 3.2) Sample collection and testing indicators
[0095] ① Body weight: Measure the body weight of each group of mice every 4 weeks
[0096] ② Blood sugar: After fasting for 8 hours (8AM-4PM), blood was collected from the tail vein and the fasting blood sugar levels of mice in each group were measured using a Johnson & Johnson One Touch Steady Blood Glucose Meter;
[0097] ③ Urine specimens: At 12 weeks, 16 weeks and 20 weeks of age, mice in each group were placed in metabolic cages and fasted for 24 hours with free access to water. The 24-hour urine was collected and centrifuged at 3000 rpm / min for 5 minutes to remove the residue. The supernatant was divided into EP tubes and stored in a -20°C refrigerator. The total 24-hour urinary albumin and urinary albumin / creatinine ratios (ACR) were tested. The 24-hour urinary albumin and urinary creatinine were tested by Roche Cobas-8000 automatic biochemical analyzer and its supporting reagents.
[0098] ④ Blood specimens: After the mice were raised to 16 weeks of age, they were anesthetized by intraperitoneal injection of 10% chloral hydrate; the abdominal cavity was opened, the abdominal aorta was separated, 5 mL of abdominal aortic blood was drawn, and the blood was allowed to stand at room temperature for 2 h, centrifuged at 2000 rpm / min for 10 min, and the serum was separated and dispensed into EP tubes for testing of serum urea nitrogen (BUN) and serum creatinine (Scr); BUN and Scr were tested by urease coupling rate method and picric acid method, respectively, using Roche fully automatic biochemical analyzer Cobas-8000 and its supporting reagents;
[0099] ⑤ Kidney specimens: After blood specimens were collected, the kidneys were immediately exposed, the capsules were removed, the bilateral kidneys were freed, the left kidney was removed, the blood was blotted with filter paper and weighed, and then stored in a -80°C refrigerator; then the blood vessels were quickly blocked above and below the renal artery with hemostatic forceps, the inferior vena cava was cut open, and the right kidney was irrigated with cold saline; the tissue of the right kidney was cut through the renal hilum coronal plane, fixed with 4% paraformaldehyde, embedded in paraffin and sliced for pathological HE, PAS, Masson staining and immunohistochemical staining observation;
[0100] 3.3) Preparation of paraffin sections of kidney
[0101] ① Cut off half of the kidney tissue on the right ventral side and fix the tissue block;
[0102] ② Dehydration and transparency: alcohol gradient (75% alcohol, 85% alcohol, 90% alcohol, 95% alcohol, anhydrous alcohol I, anhydrous alcohol II, dehydration time of each level of alcohol 0.5-1h), xylene 15min twice;
[0103] ③Wax embedding: immerse the transparent tissue block in melted paraffin for 2-4 hours, and trim the wax block to make the section smooth;
[0104] ④ Sectioning: Soak the embedded wax block in ice water for more than 24 hours, and then cut it into slices with a thickness of 4-5μm using a semi-automatic paraffin slicer. Spread it in a water bath for spreading slices, pick up the spread slices with a slide, dry them in a 37℃ oven, and store them at room temperature for later use; There were 6 mice in each group, and 2 slices were randomly selected from the kidneys of each mouse. Six glomerular fields were randomly photographed in each slice for the following tissue morphology and immunohistochemical staining analysis;
[0105] 3.4) Hematoxylin-eosin (HE) staining of kidney tissue
[0106] ① Dewaxing and hydration: dewaxing in xylene I for 10 min; dewaxing in xylene II for 10 min; hydrating in 100% alcohol (3 min) - 100% alcohol (3 min) - 90% alcohol (3 min) - 80% alcohol (3 min), respectively, and washing with tap water;
[0107] ②Hematoxylin staining: stain the nucleus with hematoxylin solution for 5-10 minutes; wash with tap water;
[0108] ③ Alcohol differentiation: 1% hydrochloric acid alcohol differentiation for 0.5-1min, rinse with running tap water, blue in saturated lithium carbonate solution for 1min, rinse with running water;
[0109] ④Eosin staining: counterstain with eosin aqueous solution for 5 minutes, then wash with tap water;
[0110] ⑤ Dehydration and transparency: dehydrate in 100% alcohol I (3 min) - 100% alcohol II (3 min) - 100% alcohol III (3 min); transparent in xylene I for 5 min, transparent in xylene II for 5 min;
[0111] ⑥Seal the slide: add an appropriate amount of neutral gum, seal with a coverslip, and observe under a microscope;
[0112] ⑦ Image semi-quantitative analysis: Observe under a 400x microscope, randomly select 6 glomerular fields from each mouse kidney section, the cytoplasm and red blood cells are in different shades of red, and the nucleus is blue; the glomerular area is calculated using Image-J 2.0 image analysis software;
[0113] 3.5) Periodic acid-Schiff (PAS) staining of kidney tissue
[0114] ① Dewaxing and hydration: dewaxing in xylene I for 10 min; dewaxing in xylene II for 10 min; hydrating in 100% alcohol I (3 min) - 100% alcohol II (3 min) - 90% alcohol (3 min) - 80% alcohol (3 min), and washing with tap water;
[0115] ② Oxidation: 1% periodic acid solution for 10 minutes, then rinse thoroughly with distilled water;
[0116] ③ Staining: Schiff reagent 1-3min, sulfite rinse 2min×3 times, running tap water rinse;
[0117] ④Re-staining: Re-stain the nucleus with hematoxylin for 3-5 minutes, and wash with tap water;
[0118] ⑤ Alcohol differentiation: 1% hydrochloric acid alcohol differentiation, rinse with tap water;
[0119] ⑥ Dehydration and transparency: dehydrate in 100% alcohol I (3 min) - 100% alcohol II (3 min) - 100% alcohol III (3 min); transparent in xylene I for 5 min, transparent in xylene II for 5 min;
[0120] ⑦Seal the slide: add an appropriate amount of neutral gum, seal with a coverslip, and observe under a microscope;
[0121] ⑧ Semi-quantitative image analysis: 6 glomerular fields were randomly selected from each mouse kidney section under a 400x microscope. PAS-positive substances (mesangial matrix) were purple-red and nuclei were blue. Image-J 2.0 image analysis software was used to analyze the mesangial matrix (purple) area and glomerular area, and the mesangial matrix index (mesangial matrix area / glomerular area × 100%) was calculated.
[0122] 3.6) Masson trichrome staining of kidney tissue
[0123] ① Dewaxing and hydration: dewaxing in xylene I for 10 min; dewaxing in xylene II for 10 min; hydrating in 100% alcohol I (3 min) - 100% alcohol II (3 min) - 90% alcohol (3 min) - 80% alcohol (3 min), and washing with tap water;
[0124] ②Hematoxylin staining: stain the nucleus with hematoxylin solution for 10-15 minutes, then wash with tap water;
[0125] ③ Alcohol differentiation: 1% hydrochloric acid alcohol differentiation, rinse with tap water for 5 minutes
[0126] ④ Fumarinization: Use Masson Ponceau acidic fuchsin solution for 5-10 minutes, and then soak in 2% glacial acetic acid aqueous solution for a while;
[0127] ⑤ Aniline blue staining: differentiate with 1% phosphomolybdic acid aqueous solution for 3-5 minutes, then directly stain with aniline blue for 5 minutes without washing, and rinse with 0.2% glacial acetic acid aqueous solution for a while;
[0128] ⑥ Dehydration and transparency: dehydrate in 100% alcohol I (3 min) - 100% alcohol II (3 min) - 100% alcohol III (3 min); transparent in xylene I for 5 min, transparent in xylene II for 5 min;
[0129] ⑦Seal the slide: Add an appropriate amount of neutral gum, seal with a coverslip, and observe under a microscope.
[0130] ⑧ Semi-quantitative image analysis: Six glomerular fields were randomly selected from each mouse kidney section under a 400x microscope. Collagen fibers appeared blue, and cytoplasmic red blood cells and cellulose appeared red. Image-Pro Plus 6.0 image software was used to analyze the collagen fiber positive staining (blue) area and glomerular area, and the percentage of Masson trichrome positive staining area was calculated (collagen deposition area / glomerular area × 100%).
[0131] 3.7) Immunohistochemistry
[0132] ① Dewaxing and hydration: Place the paraffin sections in a 60-degree drying oven for 2 hours before dewaxing; take out the paraffin sections and put them into a slide rack and place the following reagents in sequence: dewaxing in xylene I for 10 minutes; dewaxing in xylene II for 10 minutes; hydrating in 100% alcohol I (3 minutes) - 100% alcohol II (3 minutes) - 90% alcohol (3 minutes) - 80% alcohol (3 minutes); - tap water (5 minutes)
[0133] ② Antigen repair: Pour sodium citrate antigen repair solution into the pressure cooker, put in paraffin sections after boiling, tighten the lid, and turn off the pressure cooker after 2 minutes after the pressure cooker makes a sound; rinse the pressure cooker under the faucet until the valve opens, open the lid, put the entire pot in a basin filled with cold water, and cool at room temperature for 15 minutes; wash with PBS 3 times, 3 minutes each time;
[0134] ③ Eliminate peroxidase: Shake dry, wipe dry, draw a circle on the tissue area with an immunohistochemical pen, spread it in an incubation box, drop 3% H2O2 and incubate at room temperature for 10 minutes; wash with PBS 3 times, 3 minutes each time;
[0135] ④ Blocking: wipe dry, drip 1×BLOCKING REAGENTS to block for 15 minutes;
[0136] ⑤ Primary antibody incubation: wipe dry, add 200 μL primary antibody, incubate at room temperature for 1-2 hours, wash 3 times with PBS, 3 minutes each time; for the negative control group, the slices were incubated with PBS instead of primary antibody;
[0137] ⑥ Secondary antibody incubation: wipe dry, add secondary antibody, incubate at room temperature for 40 minutes, wash 3 times with PBS, 3 minutes each time;
[0138] ⑦DAB color development: DAB color development for 5 minutes, and then rinse thoroughly with tap water;
[0139] ⑧Hematoxylin counterstaining: 5-30s, rinse thoroughly with tap water;
[0140] ⑨ Dehydration and transparency: dehydrate in 100% alcohol I (3 min) - 100% alcohol II (3 min) - 100% alcohol III (3 min); transparent in xylene I for 5 min, transparent in xylene II for 5 min;
[0141] ⑩Seal the slide: Add an appropriate amount of neutral gum, seal with a coverslip, and observe under a microscope;
[0142] ⑾ Semi-quantitative image analysis: Observe under a 400x microscope, and randomly select 6 glomerular fields from each mouse kidney section; use Image-Pro Plus 6.0 image analysis software to analyze the optical density of glomerular positive staining (brown-yellow) and the percentage of glomerular area, and calculate the average optical density value (IOD / area); 3.8)
[0144] 3.81) Total protein extraction from tissues;
[0145] ① For the kidney tissues of each group of mice, weigh them and wash them with 4°C pre-cooled PBS buffer;
[0146] ② Absorb PBS with a cotton ball and place it on a grinding dish;
[0147] ③ Add 10 μL of protease inhibitor (100 mM) to 1 mL of total protein extraction lysis buffer, shake well and place on ice;
[0148] ④ Add 20 μL of total protein extraction and lysis buffer containing protease inhibitors to every 1 mg of tissue and grind thoroughly with a grinding rod;
[0149] ⑤ Use a pipette to transfer the tissue fragments and lysate into a 1.5 mL centrifuge tube and place it in a 4°C refrigerator for 30 minutes, shaking every 10 minutes to ensure that the cells are fully lysed;
[0150] ⑥ Centrifuge at 14000 rpm / min for 15 min at 4°C;
[0151] ⑦ Transfer the supernatant after centrifugation into new 1.5 mL EP tubes and store them in a -80 °C refrigerator for subsequent experiments;
[0152] 3.82) BCA method for determination of tissue protein concentration
[0153] ① Dilute the BCA standard: Dilute the BCA standard with the same diluent as the protein sample to be tested according to the following table:
[0154]
[0155] ② Calculate the total volume of BCA working solution: total volume of BCA working solution = (7 BCA standard samples + each group of samples) × 3 replicate wells × 200 μL / volume of working solution for each sample;
[0156] ③ According to the calculated total amount of BCA working solution required, mix BCA-A solution and BCA-B solution in a volume ratio of 50:1 to prepare BCA working solution, mix thoroughly, and use on the same day;
[0157] ④ Take 25 μL of protein standard from the diluted AG tube and add it to the standard wells of the 96-well plate. Tissue samples should be diluted 10 times in advance, and the original solution should be used for cell lysate samples. Take 5 μL of the sample to be tested and add it to the 96-well plate, with 3 duplicate wells for each sample, and add 20 μL of standard diluent until the volume of each well is 25 μL.
[0158] ⑤ Add 200 μL BCA working solution to each well and place at 37°C for 30 min;
[0159] ⑥ The microplate reader detects the optical density value at a wavelength of 562 nanometers, calculates the standard curve based on the known concentration of the standard protein and the optical density value obtained by the test, and then calculates the protein concentration of the sample based on the standard curve;
[0160] ⑦ According to the calculated protein concentration, adjust the sample protein concentration to the same level as the lowest concentration sample with protein lysis buffer, add 1 / 4 volume of 5×SDS protein loading buffer according to the corresponding volume, mix well, boil at 95℃ for 5 minutes, and store in a -80℃ refrigerator for later use;
[0161] 3.83) SDS-PAGE electrophoresis and immunoblotting
[0162] ① Make separation gel and concentrated gel: First, clean the glass plate, rinse it with distilled water, and then stand it on a rack to dry. Align the bottom of the glass plate and put it into the gel clamp to clamp it, and fix it on the gel rack to prevent leakage. Prepare separation gel of appropriate concentration according to the above method. After adding TEMED, quickly mix the gel and pour it into the glass plate sandwich to about 2 / 3 of the height, then add a layer of water sealant on the gel and wait for the separation gel to solidify. After standing for about 25-30 minutes, when an obvious refraction line appears between the water and the separation gel, it indicates that the separation gel has solidified. Wait for another 3 minutes to allow the separation gel to solidify. After the gel is fully solidified, pour off the upper water and use absorbent paper to absorb the remaining liquid; Make concentrated gel: prepare concentrated gel according to the above method; after adding TEMED, quickly mix the gel to fill the remaining space between the glass plates, then insert the comb, wait for the concentrated gel to solidify, and pay attention to avoid the generation of bubbles; after standing for about 25-30 minutes, the concentrated gel is completely solidified, put the glass plate into the electrophoresis tank correctly, clamp it to prevent leakage; then prepare 1000mL of 1× electrophoresis buffer, mix it well and add it to the space between the glass plates and the electrophoresis tank, carefully pull out the comb, and prepare to load the sample;
[0163] ② Loading: Thaw the -80℃ standby protein samples and place them on ice; adjust the loading volume of each group of protein samples according to the BCA concentration and load them with 5μL pre-stained Marker. Pay attention to loading slowly and evenly to avoid overflow of the sampled eggs that may affect the results;
[0164] ③ Electrophoresis: Set the constant voltage to 80V at the beginning of electrophoresis. When the front of bromophenol blue enters the separation gel and the pre-stained marker is separated, adjust the voltage to 120V. Stop the electrophoresis when the bromophenol blue reaches the bottom of the separation gel.
[0165] ④ Transfer: We use wet transfer; according to the size of the gel, cut 6 thin filter papers (about 7.0-8.3cm long) and a PVDF membrane (about 7.3-8.6cm long); prepare 1× transfer buffer 1000mL according to the above method, and soak the PVDF membrane in a liquid containing 100% methanol for about 5 minutes, then transfer it to the transfer buffer and place it for 5 minutes, and soak the filter paper in the transfer buffer; after the electrophoresis, carefully separate the large and small glass plates to avoid pulling and damaging the gel plates, and pay attention to prevent the gel surface from drying, cut off the concentrated gel, and cut off the required part according to the marker according to the molecular weight of the target protein; from bottom (black film, negative electrode) to top (white film, anode), place a layer of sponge, three layers of filter paper, a piece of separation gel, PVDF membrane, three layers of filter paper, and a layer of sponge in order, as shown in the following figure:
[0166] Then tighten the transfer clamp, and avoid bubbles in each layer during the operation; put the clamp into the transfer tank, so that the black side of the clamp corresponds to the black side of the tank, and the white side corresponds to the red side of the tank; add an appropriate amount of freshly prepared electrotransfer buffer and perform electrotransfer in an ice bath; set a constant voltage of 100 volts for 95 minutes;
[0167] ⑤ Blocking: After the transfer, take out the PVDF membrane, rinse it with TBST at room temperature for 3 times, 5 minutes each time, and then soak it in 5% skim milk blocking solution prepared according to the above formula, and block it on a shaker at room temperature for 1 hour;
[0168] ⑥ Primary antibody incubation: In a 15mL centrifuge tube, dilute the primary antibody to an appropriate concentration with primary antibody diluent and shake well. The ratio of primary antibody is as follows: Col. IV (1:1000); FN (1:1000); α-SMA (1:100); Hunk (1:1000); p62 (1:2500); LC3B (1:1000); Beclin-1 (1:2000); Tubulin (1:5000); p-TSC2 (1:1000); TSC2 (1:1000): p-mTOR (1:1000); mTOR (1:1000); Take out the blocked PVDF membrane, rinse it 3 times with TBST on a shaker at room temperature, 5 minutes each time, then put it into the primary antibody incubation box, and incubate it overnight at 4°C; Wash the PVDF membrane incubated with primary antibody 3 times with TBST on a shaker at room temperature, 10 minutes each time;
[0169] ⑦ Secondary antibody incubation: Prepare the corresponding secondary antibody with TBST at a dilution ratio of 1:5000, and shake gently to mix; put the washed PVDF membrane into the prepared corresponding secondary antibody and incubate on a shaker at room temperature for 1 hour; wash the PVDF membrane incubated with secondary antibody 3 times with TBST on a shaker at room temperature, 10 minutes each time;
[0170] ⑧ Chemiluminescence and exposure: Prepare the working solution of Extracellular chemiluminescene (ECL) luminescent solution A and B in a 1:1 ratio, mix thoroughly, and place the membrane protein side down in contact with the mixed solution for 1 minute; remove all the residual liquid, move the membrane to another plastic wrap (to avoid bubbles), wrap it, put it into the AlphaEaseFC imaging system for exposure, and save the image;
[0171] ⑨ Image analysis: Use Image J image processing system to analyze the optical density value of the target band; calculate the ratio of the optical density value of the target band to the internal reference band to reflect the relative level of the protein;
[0172] 3.9) Statistical analysis
[0173] GraphPad Prism 9 software was used for statistical analysis. All data were expressed as mean ± SEM. Paired t-test was used for comparison between two groups, and one-way ANOVA was used for comparison between multiple groups. P < 0.05 was considered statistically significant.
[0174] Embodiment 2:
[0175] 2. In vitro experiments: 1) Rat mesangial cells (RMC) were cultured in vitro and divided into a normal glucose group (NG, 5.5 mM glucose) and a high glucose group (HG, 25 mM glucose). After 48 h of culture, Western Blot was used to detect the expression of Hunk protein, autophagy marker proteins (LC3, Beclin-1, p62) and fibrosis proteins (Fibronectin, Col IV, α-SMA) in total protein;
[0176] 2) Under high glucose induction, the autophagy activator rapamycin (Rapa) was used to enhance RMC autophagy: a normal glucose group (NG, 5.5 mM glucose), a high glucose group (HG, 25 mM glucose), and a rapamycin group (Rapa, HG + Rapamycin) were set up; after 48 hours of intervention, Western Blot was used to detect the expression of autophagy marker proteins (LC3, Beclin-1, p62) and fibrosis proteins (Fibronectin, Col IV, α-SMA);
[0177] 3) Overexpression plasmid was used for transient transfection to obtain RMC overexpressing Hunk, and the effect of enhancing Hunk expression on high glucose-induced RMC autophagy and fibrosis was investigated; the experiment was divided into 5 groups: normal glucose group (NG, 5.5 mM glucose), high glucose group (HG, 25 mM glucose), blank control group (NC, HG+pcDNA3.1-vector), Hunk overexpression group (OE-Hunk, HG+pcDNA3.1-Hunk), and rapamycin intervention group (Rapa, HG+pcDNA3.1-Hunk+Rapamycin); Western Blot was used to detect the expression of Hunk protein, autophagy marker proteins (LC3, Beclin-1, p62), fibrosis proteins (Fibronectin, Col IV, α-SMA) and TSC2-mTOR pathway proteins (p-TSC2, TSC2, p-mTOR, mTOR) after 48 hours of intervention.
[0178] The specific description is as follows;
[0179] 1) Experimental Materials
[0180] 1.1) Cell lines
[0181] Rat glomerular mesangial cell line (HBZY-1) Prosai Corporation (catalog CL-0092)
[0182] 1.2) Drugs and reagents
[0183]
[0184]
[0185]
[0186] 1.3) Instruments and equipment
[0187]
[0188]
[0189] 2) Reagent configuration
[0190] 2.1) Culture medium preparation
[0191] ①10% fetal bovine serum low-glucose medium preparation: Take 89 mL of GIBCO low-glucose medium (LDMEM), add 10 mL of fetal bovine serum and 1 mL of penicillin-streptomycin double antibody, filter and sterilize using a 0.45 μm Millpore filter, and store in a 4°C refrigerator;
[0192] ②10% fetal bovine serum high glucose medium preparation: Take 89 mL of GIBCO high glucose medium (HDMEM), add 10 mL of fetal bovine serum and 1 mL of penicillin-streptomycin double antibody, filter and sterilize using a 0.45 μm Millpore filter, and store in a 4°C refrigerator;
[0193] ③0.5% fetal bovine serum low-glucose medium preparation: Take 98.5mL of GIBCO low-glucose medium (LDMEM), add 0.5mL of fetal bovine serum and 1mL of penicillin-streptomycin double antibody, filter and sterilize with a 0.45μm Millpore filter, and store in a 4℃ refrigerator;
[0194] ④ Preparation of 0.5% fetal bovine serum high-glucose medium: Take 98.5mL of GIBCO high-glucose medium, add 0.5mL of fetal bovine serum and 1mL of penicillin-streptomycin double antibody, filter and sterilize with a 0.45μm Millpore filter, and store in a 4℃ refrigerator;
[0195] 2.2) The rapamycin stock solution is 10 mmol / L and is stored in a -80°C refrigerator; 0.54 μL of the rapamycin stock solution is added to an EP tube containing 20 mL of cell culture medium and mixed thoroughly to prepare a culture medium with a final rapamycin concentration of 250 ng / ml for cell intervention;
[0196] 3) Research methods
[0197] 3.1) Culture method of rat glomerular mesangial cells;
[0198] ① Preparation: clean bench, 37℃ constant temperature water bath, 37℃ rewarming complete culture medium and 0.25% trypsin, PBS, culture bottle, ice box, tweezers, etc.;
[0199] ② Cell recovery: Take out the cryopreservation tube from the -80℃ refrigerator, quickly put it into a 37℃ constant temperature water bath, and shake it gently to thaw it quickly; then take out the cell cryopreservation tube, disinfect it with 75% alcohol, and place it in a sterile clean bench; aspirate the cell freezing solution, inject it into a 6mL centrifuge tube containing 10% fetal bovine serum low-glucose medium and mix it, centrifuge it at 1000rpm / min for 5min, discard the supernatant, add 1mL 10% fetal bovine serum low-glucose medium, gently blow and resuspend it, and then inoculate it into a 75cm2 breathable culture bottle, add culture medium to 10mL, and place it in a 37℃, 5% CO2 constant temperature sterile incubator for culture; change the medium every 2-3 days according to the cell growth and the pH value of the culture medium;
[0200] ③Cell passaging: When the RMC cell fusion degree reaches about 80-90%, cell passaging is performed; use a sterile Pasteur pipette to absorb the cell culture medium, wash the cells 1-2 times with sterile PBS2-3mL, add 0.25% EDTA-free trypsin 2mL, until the cell layer on the wall of the culture bottle is completely covered, and place it in a 37℃ constant temperature sterile incubator for digestion for 2min. When the cell gap is significantly enlarged and some cells become round under the microscope, add 6mL 10% fetal bovine serum low-glucose medium and gently blow the cells at the bottom of the bottle to make the cells fall off the wall and mix them. Transfer the cells and the culture medium into a centrifuge tube, centrifuge at 1000rpm / min for 5min, discard the supernatant, add 35mL 10% fetal bovine serum low-glucose medium, gently blow and resuspend, and then inoculate into the culture bottle at a ratio of 1:3, add the culture medium to 10mL, and place it in a 37℃, 5% CO2 constant temperature sterile incubator for culture;
[0201] ④ Cell freezing: Take RMC in good condition in the logarithmic growth phase for freezing; replace fresh culture medium 24 hours before freezing; digest the cells according to the cell passaging method and collect the cells by centrifugation, discard the supernatant, resuspend the cells with serum-free cell freezing medium, adjust the cell concentration to 5×105 / mL~1×107 / mL single cell suspension, dispense into sterile cryopreservation tubes, 1mL per tube, seal tightly, and mark the cryopreservation tubes (cell name, generation, freezing date, cryopreservation); directly put the dispensed cell cryopreservation tubes into a -80℃ ultra-low temperature refrigerator for long-term freezing and storage;
[0202] 3.2) According to the aforementioned cell passaging method, the cells in the culture flask were digested and resuspended, and then evenly inoculated into a 60 mm cell culture dish at an appropriate density, with 5 mL of culture medium per well; when the RMC reached 80% cell confluence, the original low-glucose cell culture medium was aspirated, and the cells were starved overnight with 0.5% fetal bovine serum DMEM cell culture medium to stop growth, and then various experimental treatments were performed;
[0203] ①Observe the effect of high glucose stimulation on the expression of RMC Hunk protein, autophagy marker protein and fibrosis protein:
[0204] The experiment was divided into 2 groups: (1) normal glucose control group (NG): normal glucose concentration (5.5mM) LDMEM culture medium; (2) high glucose intervention group (HG): high glucose concentration (25mM) HDMEM culture medium; intervention culture was terminated after 48 hours, and the total protein of each group was collected. Western Blot was used to detect the expression of Hunk protein, autophagy marker proteins (LC3, Beclin-1, p62) and fibrosis proteins (Fibronectin, Col IV, α-SMA) in the total protein;
[0205] ② Under high glucose induction, the autophagy activator rapamycin (Rapa) was used to enhance the autophagy activity of RMC, and the effect of upregulating autophagy activity on the expression of ECM proteins in RMC induced by high glucose was observed:
[0206] The experiment was divided into 3 groups: (1) normal glucose control group (NG): normal glucose concentration (5.5mM) LDMEM culture medium; (2) high glucose intervention group (HG): high glucose concentration (25mM) HDMEM culture medium; (3) 250ng / ml rapamycin intervention group (HG+Rap): 25mM HDMEM culture medium + 250ng / ml rapamycin; the culture was terminated after 48 hours, and the cell proteins of each group were collected. Western Blot was used to detect the expression of autophagy marker proteins (LC3, Beclin-1, p62) and fibrosis proteins (Fibronectin, Col IV, α-SMA);
[0207] ③Use pcDNA 3.1-Hunk transient transfection to obtain RMC overexpressing Hunk, and explore the effect of enhancing Hunk expression on high glucose-induced RMC autophagy and fibrosis:
[0208] The experiment was divided into 5 groups: (1) normal glucose group (NG): normal glucose concentration (5.5mM) LDMEM culture medium; (2) high glucose intervention group (HG): high glucose concentration (25mM) HDMEM culture medium; (3) empty plasmid group (HG+NC): 25mM HDMEM culture medium + pcDNA3.1-vector; (4) Hunk overexpression group (OE-Hunk): 25mM HDMEM culture medium + pcDNA 3.1-Hunk; (5) rapamycin intervention group (HG+pcDNA 3.1-Hunk+Rapamycin): 25mM HDMEM culture medium + pcDNA 3.1-Hunk + 250ng / ml rapamycin; After transfection in serum-free medium for 6 hours, normal glucose or high glucose medium or high glucose medium containing 250ng / ml rapamycin was added, and the culture was terminated after 48 hours. The cell proteins of each group were collected and Western blot was performed. Blot was used to detect the expression of Hunk protein, autophagy marker proteins (LC3, Beclin-1, p62), fibrosis proteins (Fibronectin, Col IV, α-SMA), and TSC2-mTOR pathway proteins (p-TSC2, TSC2, p-mTOR, mTOR) in total protein;
[0209] 3.3) pcDNA3.1 transient transfection
[0210] ① Cell plating: Digest and resuspend the cells in the culture flask according to the aforementioned cell passaging method, and then evenly inoculate them in a 6-well plate at an appropriate density, with 2 mL of culture medium per well; when the RMC reaches 60%-80% cell confluence, perform the following experimental treatments;
[0211] ② Preparation of transfection complex: Place GP-transfect-Mate transfection reagent at room temperature before use and gently mix before use; add 50μg plasmid to 100μL DEPC water to prepare 500ng / μL liquid; add 750μL serum-free culture medium or OPTI-MEM to a 1.5mL sterile centrifuge tube, add 4μL transfection reagent Lipo 2000, mix gently with a pipette, and let stand at room temperature for 5min (A solution); at the same time, add 750μL serum-free culture medium or OPTI-MEM to another 1.5mL sterile centrifuge tube, add 8μL pcDNA3.1, mix gently with a pipette, and let stand at room temperature for 5min (B solution); add A solution dropwise to B solution, do not reverse the mixing order, mix gently with a pipette, let stand at room temperature for 15-20min before transfection;
[0212] ③ Transfection process; While standing, rinse the 6-well plate with serum-free medium or OPTI-MEM, and replace each well with 500 μL preheated serum-free medium or OPTI-MEM; add 1.5 mL of transfection mixture to the wells of the six-well plate, and the final system is 2 mL; after adding, gently shake the plate to evenly distribute the complex; culture the cells at 37°C, and after 6 hours, replace it with 0.5% fetal bovine serum low-glucose medium and continue to culture for 48 hours. After that, replace it with 0.5% fetal bovine serum low-glucose medium or 0.5% fetal bovine serum high-glucose medium or 0.5% fetal bovine serum high-glucose medium containing 250 ng / ml rapamycin according to the experimental grouping and continue to culture for 48 hours, and then collect the cells to detect protein expression;
[0213] ④pcDNA3.1-Hunk sequence: Hunk: NM_001191662.2;
[0214] 3.4) Western blot detection of protein expression
[0215] ① Total protein extraction of cells; For cells cultured in each group, discard the cell culture medium; Wash the cells three times with 4℃ pre-cooled PBS buffer, discard the PBS and place the culture dish on ice; Add 10μL protease inhibitor (100mM) to 1mL total protein extraction lysis buffer, shake well and place on ice; Add 200μL total protein extraction lysis buffer containing protease inhibitors to each 60mm culture dish cell and lyse on ice for 5min; Use a clean cell scraper to scrape the cells on one side of the culture dish (move quickly), then use a pipette to transfer the cell fragments and lysis buffer to a 1.5mL centrifuge tube, put it in a 4℃ refrigerator for 30min, shake well every 10min to ensure that the cells are fully lysed; Centrifuge at 4℃ and 14000rpm / min for 15min; Transfer the supernatant after centrifugation to a new 1.5mL EP tube and store it in a -80℃ refrigerator for subsequent experiments;
[0216] ②SDS-PAGE electrophoresis and immunoblotting: Same as animal experiments;
[0217] ③ Use Image J image processing system to analyze the optical density value of the target band; calculate the ratio of the optical density value of the target band to the internal reference band to reflect the relative level of the protein;
[0218] 3.5) Statistical analysis
[0219] GraphPad Prism 9 software was used for statistical analysis. All data were expressed as mean ± SEM. Paired t-test was used for comparison between two groups, and one-way ANOVA was used for comparison between multiple groups. P < 0.05 was considered statistically significant.
[0220] From the above, we can see that; combined Figure 1-Figure 8 ;
[0221] like Figure 1 As shown in (AB), mice in the DN group began to develop hyperglycemia after 8 weeks of age, and their body weight was significantly higher than that of mice in the NC group, which lasted until 20 weeks. At the same time, mice in the DN group began to develop albuminuria at 12 weeks of age, and showed obvious DN symptoms after 16 weeks of age, with urine 24h mAlb, ACR, SCr and BUN levels significantly higher than those in the NC group.
[0222] like Figure 2 As shown in (AC), compared with the non-diabetic control group mice, the 16-week-old DN group mice showed typical glomerular sclerosis, glomerular basement membrane thickening and mesangial expansion, and the mesangial matrix index of the DN group mice was significantly higher than that of the NC group mice. At the same time, Masson staining showed that the staining positive area on the kidney sections of the DN group mice was significantly increased compared with that of the normal group mice, indicating that the degree of renal fibrosis was significantly increased ( Figure 2 A and 2D);
[0223] like Figure 3 As shown in AD, the immunohistochemical results showed that the expression of glomerular fibrosis proteins FN, Col IV and α-SMA in the DN group was significantly enhanced compared with the NC group; at the same time, Western Blot results showed that the expression of renal cortical fibrosis proteins FN, Col IV and α-SMA in the DN group was significantly higher than that in the NC group ( Figure 3 EF);
[0224] Depend on Figure 4 It can be seen that in order to clarify the glomerular autophagy activity and Hunk protein expression in db / db mice, we used immunohistochemistry to detect the expression of LC3B and Hunk proteins in the glomeruli of db / db mice, and western blotting to detect the expression of LC3, Beclin-1, p62 and Hunk proteins in the renal cortex of db / db mice; Figure 4 A and Figure 4 CD, Immunohistochemistry results showed that the expression of Hunk protein and LC3B protein in the glomerulus of DN mice was reduced; at the same time, Western blot results showed that compared with the NC group mice, the expression of Hunk protein in the renal cortex of DN mice was reduced ( Figure 4 B and 4E), the LC3II / LC3I ratio was significantly decreased, Beclin-1 expression was decreased, and the expression level of p62 was significantly upregulated ( Figure 4 B and 4F); The above results suggest that the expression of Hunk protein in the glomeruli of db / db DN mice is reduced, and the autophagic activity is also reduced;
[0225] Depend on Figure 5 It can be seen that in the in vitro experiment, RMC was cultured in a medium containing 5.5mM (NG) or 25mM (HG) glucose concentration for 48h, and the expression of fibrosis indicators (FN, α-SMA and Col IV), Hunk protein and autophagy indicators (LC3, p62 and Beclin-1) were detected by Western Blot; Figure 5 As shown in (AB), the expression of fibrotic proteins FN, Col IV and α-SMA in the HG group was significantly higher than that in the NG group, while the expression of Hunk protein was significantly lower than that in the NG group ( Figure 5 CD); at the same time, compared with the NG group, the LC3II / I ratio and Beclin-1 protein expression in the HG group were significantly decreased, and the p62 protein expression was significantly increased ( Figure 5 EF), indicating that autophagic activity decreased; the above results suggest that high glucose stimulation inhibits RMC autophagic activity and Hunk protein expression, while promoting the production of fibrotic proteins;
[0226] Depend on Figure 6It is known that autophagy activity is inhibited in diabetic mice and RMC cultured in high glucose. To further explore the role of autophagy activity in regulating fibrotic proteins in DN, we used the autophagy activator rapamycin to intervene in RMC under high glucose conditions for 48 hours, and used Western blotting to clarify the autophagy status and expression of fibrotic proteins in RMC after rapamycin intervention; the results are shown in Figure 2. Figure 6 As shown in A and 6C, under the intervention of rapamycin, the expression of Beclin-1 protein and the LC3II / I ratio in the HG group were upregulated, and the expression of p62 protein was downregulated, indicating that the autophagic activity was partially restored; it has been previously shown that the expression of FN, Col IV, and α-SMA proteins in the HG group was significantly increased compared with the NG group, and after the use of rapamycin to intervene in RMC under high glucose conditions, the expression of FN, Col IV, and α-SMA was reduced compared with the HG group ( Figure 6 B and 6D); The above results show that restoring RMC autophagy activity can inhibit the production of fibrotic proteins induced by high glucose;
[0227] Depend on Figure 7 It can be seen that under high glucose conditions, the autophagic activity of RMC decreases, thereby promoting the production of fibrotic proteins. At the same time, the expression of Hunk protein in RMC induced by high glucose decreases. In order to clarify whether Hunk protein can regulate autophagic activity and thus affect the fibrosis of RMC, we used pcDNA 3.1 recombinant plasmid to overexpress Hunk gene and enhance the expression of Hunk protein in RMC. Western Blot was used to determine the expression of Hunk, autophagic marker proteins and fibrotic proteins. The results are shown in Figure 2 Figure 7 As shown, compared with the NC group, the expression of Hunk protein in the OE-Hunk group was significantly upregulated ( Figure 7 AB), while Beclin-1 protein expression and LC3II / I ratio were upregulated, and p62 protein expression was downregulated ( Figure 7 GJ), indicating that enhancing Hunk protein expression can partially restore high glucose-induced autophagy activity in RMC; at the same time, the expression of FN, Col IV, and α-SMA proteins in the OE-Hunk group was significantly lower than that in the NC group ( Figure 7 CF); combined with the above research results, it is suggested that overexpression of Hunk protein can partially restore the autophagic activity of RMC under high glucose conditions, thereby reducing the excessive production of fibrotic proteins;
[0228] Depend on Figure 8 It is known that the TSC2-mTOR pathway plays an important role in cell proliferation and growth, and mTOR plays an important role in the regulation of autophagy; however, it is still unclear whether Hunk protein participates in the pathogenesis of diabetic nephropathy by regulating autophagy through the TSC2-mTOR pathway;
[0229] like Figure 8AD, Western Blot results showed that compared with the NG group, the expression of p-TSC2 and p-mTOR proteins in the HG group was reduced, and the p-TSC2 / TSC2 ratio and p-mTOR / mTOR ratio were reduced, indicating that high glucose can activate the activity of the TSC2-mTOR pathway in RMC; on the contrary, the expression of p-TSC2 and p-mTOR proteins in the OE-Hunk group was significantly lower than that in the NC group, and the p-TSC2 / TSC2 and p-mTOR / mTOR ratios were reduced, indicating that enhancing Hunk expression can downregulate the activity of the TSC2-mTOR pathway in high glucose-induced RMC; According to the previous results, autophagic activity in RMC was inhibited under high glucose intervention, and overexpression of Hunk protein can partially restore autophagic activity and reduce the expression of fibrotic proteins; In order to further explore whether Hunk protein regulates autophagic activity through the TSC2-mTOR pathway and affects the production of fibrotic proteins in RMC, we used the mTOR inhibitor-rapamycin to further inhibit the RMC mTOR activity in the Hunk overexpression group; The results are shown in Figure 8 As shown in A and 8D, compared with the OE-Hunk group, the p-mTOR protein expression and p-mTOR / mTOR ratio in the Rapa group were further reduced, while the Beclin-1 protein expression and LC3II / I ratio were further increased, and the p62 protein expression was further reduced ( Figure 8 EH), indicating that mTOR mediates the regulation of Hunk on autophagy activity; at the same time, the expression of FN, Col IV, and α-SMA proteins in the Rapa group was significantly lower than that in the Hunk overexpression group ( Figure 8 IL); In summary, overexpression of Hunk protein can reduce the inhibition of autophagy activity in RMC induced by high glucose through the TSC2-mTOR pathway and inhibit the production of fibrotic proteins;
[0230] From the above, we can see that the autophagy pathway is involved in glomerular fibrosis in DN, and Hunk protein can regulate autophagy through the TSC2-mTOR pathway to improve fibrosis of DN MCs; our research results provide a new theoretical basis and development ideas for the prevention and treatment of DN;
[0231] like Fig. 9 As shown in the results, restoring autophagic activity can reduce the excessive production of fibrotic proteins in RMC under high glucose stimulation. Hunk protein can restore the autophagic activity in RMC induced by high glucose through the TSC2-mTOR pathway and reduce the production of fibrotic proteins.
[0232] In summary, this method has the following effects:
[0233] 1. This in vivo test has the following effects:
[0234] 1) Compared with the mice in the NC group, the fasting blood glucose, body weight, Scr, BUN and ACR of the DN mice were significantly increased;
[0235] 2) Compared with the mice in the NC group, the renal cortex of DN mice showed significant glomerular hypertrophy, mesangial expansion, and a large amount of collagen fiber deposition in the interstitium.
[0236] 3) Immunohistochemical staining showed that compared with the NC group, the expression of glomerular fibrosis proteins (FN, Col IV and α-SMA) in DN mice increased, while the expression of Hunk and LC3 proteins decreased; Western Blot results showed that the expression of renal cortical fibrosis proteins (FN, Col IV and α-SMA) in DN mice increased, the expression of Hunk protein decreased significantly, and the autophagic activity decreased (the LC3II / LC3I ratio decreased, the expression of Beclin-1 decreased, and the expression of p62 increased);
[0237] 2. This in vitro test has the following effects:
[0238] 1) Under high glucose induction, Hunk protein levels and autophagy activity in RMC were downregulated (LC3II / LC3I ratio decreased, Beclin-1 expression decreased, and p62 expression increased), while the expression of fibrotic proteins (FN, Col IV, and α-SMA) increased;
[0239] 2) Under rapamycin intervention, autophagic activity in high-glucose-induced RMC was partially restored (increased LC3II / LC3I ratio, increased Beclin-1 expression, and decreased p62 expression), while the expression of fibrotic proteins (FN, Col IV, and α-SMA) was significantly reduced;
[0240] 3) Enhancing the expression of Hunk protein in RMC induced by high glucose can reduce the inhibition of autophagy activity by high glucose stimulation (increased LC3II / LC3I ratio, increased Beclin-1 expression, and decreased p62 expression), and inhibit the production of fibrotic proteins (FN, ColIV, and α-SMA);
[0241] 4) Under high glucose stimulation, the p-TSC2 protein level, p-TSC2 / TSC2, p-mTOR protein level and p-mTOR / mTOR ratio in RMC were increased; enhancing the expression of Hunk in RMC under high glucose induction could downregulate the expression levels of p-TSC2 and p-mTOR, and the p-TSC2 / TSC2 and p-mTOR / mTOR ratios were reduced; enhancing the expression of Hunk in RMC under high glucose induction and intervening with rapamycin further reduced the expression of p-mTOR and the p-mTOR / mTOR ratio, and at the same time, the autophagy activity was further restored (the LC3II / LC3I ratio increased, the Beclin-1 expression increased, and the p62 expression decreased), while the expression of fibrosis proteins (FN, Col IV and α-SMA) was further reduced.
[0242] The embodiments of the present invention are provided for the purpose of illustration and description. Although the embodiments of the present invention have been shown and described above, it can be understood that the above embodiments are exemplary and cannot be understood as limitations of the present invention. Ordinary technicians in this field can change, modify, replace and modify the above embodiments within the scope of the present invention.
Claims
1. A method for improving glomerular mesangial cell fibrosis in diabetic nephropathy by regulating autophagy via the TSC2-mTOR pathway using Hunk protein, characterized in that: The following steps are involved: S1. Construction of diabetic nephropathy mouse model: BKS-db / db mice were used to establish a diabetic nephropathy (DN) mouse model; S2. Detection of indicators and pathological evaluation of DN mice. First, the metabolic indicators and renal function of DN mice were comprehensively tested. Then, the renal sections were pathologically evaluated using HE, Masson, and PAS staining techniques. Then, Western Blot and immunohistochemical staining techniques were used to detect the distribution and expression of fibrosis proteins (FN, ColIV, α-SMA), autophagy marker proteins (LC3, Beclin-1, p62), and Hunk proteins in the renal cortex. S3. Setting of cell culture conditions: Rat glomerular mesangial cells (RMC) were cultured and two culture medium environments, low sugar and high sugar, were set respectively; S4, Hunk protein overexpression: RMCs were transiently transfected with pcDNA 3.1-Hunk plasmid; S5. Verify Hunk protein expression: Use Western Blot technology to detect the expression level of Hunk protein in RMC to confirm the transfection effect; S6. Detection of cell autophagy function: RMCs were cultured in a high-glucose environment and intervened with the autophagy activator rapamycin, and then the expression of autophagy marker proteins (LC3, Beclin-1, p62) was detected by Western Blot technology; S7. Evaluation of the degree of cell fibrosis: Western Blot technology was used to detect the expression of fibrotic proteins (FN, Col IV, α-SMA) in RMC, and the effect of Hunk overexpression on high glucose-induced RMC fibrosis was evaluated; S8. Cell signaling pathway analysis: To explore the effect of enhancing Hunk expression on the expression of TSC2-mTOR pathway proteins (p-TSC2, TSC2, p-mTOR, mTOR) in high glucose-induced RMC, so as to understand the molecular mechanism of Hunk protein in diabetic nephropathy.
2. A method for improving glomerular mesangial cell fibrosis in diabetic nephropathy by regulating autophagy via the TSC2-mTOR pathway using Hunk protein as claimed in claim 1, characterized in that: In step S5, the Western Blot technique detection operation steps are as follows: S5.
1. Protein extraction: Collect RMC cells and perform appropriate treatment, such as exposure to PBS, lyse cells with cell lysis buffer and lyse proteins; S5.
2. Determine protein content: BCA protein quantification kit or other appropriate methods can be used; S5.3, SDS-PAGE electrophoresis: separate the protein samples into SDS-PAGE gel; S5.4, membrane transfer: transfer the proteins in the SDS-PAGE gel to the polymer membrane for Western Blot reaction; S5.5, Blocking and antibody reaction: Block the membrane with 5% non-fat milk powder or other proteins, and add Hunk antibody reaction. You can choose a primary antibody labeled with an enzyme (such as HRP) and a secondary antibody labeled with a fluorescent substance to react and detect the protein level; S5.
6. Color development: Use horseradish peroxidase substrate or other suitable color developing agent to develop the target protein; S5.7 Image analysis: Quantify and analyze proteins using image analysis software.
Citation Information
Patent Citations
Hormonally up-regulated, neu-tumor-associated kinase
US20050265985A1
